That loss of CSL enhances tumor development is further underlined by a recent study reporting that combined silencing of CSL and p53 in cancer-associated fibroblasts leads to stromal and cancer cell expansion (Procopio et al., 2015). The gene discussed is TP53; the disease is neoplasm.